Source: Virtual Congress 2021 – Optimising outcomes of lung transplantation: how to move forward?



Rating:

Share or cite this content

Citations should be made in the following way:
M. Šterclová (Prague, Czech Republic), Z. Kovarikova (Prague, Czech Republic), L. Fila (Prague, Czech Republic), L. Valentova-Bartakova (Prague, Czech Republic). Interstitial lung diseases and transplantation - how to choose the best candidate?. 2909

Member's Comments

No comment yet.

Related content which might interest you: Lung transplantation: the ideal treatment for diffuse disease? Source: Annual Congress 2006 - Up to date management of bronchiectasis Year: 2006 What’s new in interstitial lung diseases in children? Source: Virtual Congress 2021 – Paediatric year in review Year: 2021 New antifibrotic drugs: will interstitial diseases patients still need lung transplantation? Source: Virtual Congress 2020 – Lung transplantation in the era of new drugs Year: 2020 What (and how) do we attain by performing surgical lung biopsy for interstitial lung disease? Source: International Congress 2015 – Interstitial lung diseases II Year: 2015 Rapid decline in lung disease other than COPD: when should lung transplantation be considered? Source: Annual Congress 2007 - Rapid decline in lung function and its consequences Year: 2007 Thoracic surgery in a potential lung transplant candidate: what is (im)possible? Source: Annual Congress 2012 - Lung transplantation in 2012: where are we? Year: 2012 Better survival outcomes after bilateral lung transplantation compared to single lung transplantation in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Clinical studies in lung transplantation Year: 2013 Selection of emphysema patients for lung transplantation today Source: Annual Congress 2004 - Lung transplantation: new insights in advanced lung disease and new drug developments - do they impact on selection criteria? Year: 2004 Interstitial lung diseases: a clinical update Source: Eur Respir J 2001; 18: 1S Year: 2001 Is sildenafil an effective bridging therapy to lung transplantation for patients with pulmonary hypertension in the setting of lung disease? Source: International Congress 2015 – Pulmonary hypertension in lung disease Year: 2015 Two new NKX2-1 mutations associated with pediatric interstitial lung diseases Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease? Year: 2009 Interstitial lung diseases today Source: Eur Respir Mon; 2009: 46: 1–3 Year: 2009 Pulmonary rehabilitation in patients with interstitial lung disease – An useful therapeutic option? Source: Annual Congress 2011 - Pulmonary rehabilitation: looking at alternative approaches and alternative populations beyond COPD Year: 2011 Lung transplantation in rare lung diseases: the problem of chronic lung allograft dysfunction (CLAD) Source: International Congress 2018 – Rare lung diseases Year: 2018 Late Breaking Abstract - Good outcome for lung transplantation for adults with interstitial lung disease associated with genetic disorders of surfactant metabolism Source: Virtual Congress 2021 – Optimising outcomes of lung transplantation: how to move forward? Year: 2021 Interstitial lung disease; where do we stand without histopathology? Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013 Multidisciplinary board for interstitial lung disease: Relevance for real life? Source: International Congress 2015 – New insights into IIPs Year: 2015